Subspecialties: Page 77

SNMMI: Theranostics method targets multiple cancers

By Amerigo Allegretto

A new radionuclide-based agent offers potential as a theranostics approach for targeting multiple cancers, suggest findings presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 27, 2023

SNMMI: Experts debate AI's role in nuclear medicine

By Will Morton

CHICAGO - AI applications in nuclear medicine are beginning to pick up steam – a good time to hit the brakes and discuss implications for the field, according to experts at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 27, 2023

AI improves lung cancer detection on chest radiographs

By Will Morton

Assistance from an AI model with high diagnostic accuracy can improve lung cancer detection and increase human acceptance of AI suggestions, regardless of reader characteristics, according to new research published in Radiology.

June 27, 2023

Blue Earth highlights Posluma study results

By AuntMinnie.com staff writers

Blue Earth Diagnostics, a Bracco company, is highlighting results from a study that explored the impact of urinary activity on the interpretation of its flotufolastat F-18 injection (Posluma).

June 26, 2023

Coreline gets Health Canada approval for Aview

By AuntMinnie.com staff writers

Advanced visualization and AI software developer Coreline Soft has secured class 3 approval from Health Canada for its Aview LCS lung cancer screening computer-aided detection software.

June 26, 2023

SNMMI: PET tracer model quantifies cardiac amyloidosis burden

By Erik L. Ridley

A tracer kinetic model can enable quantitative measurement of cardiac amyloidosis burden and assessment of treatment response, according to a study presented at the annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Chicago.

June 26, 2023

SNMMI: New therapeutic target discovered for bladder cancer

By Kate Madden Yee

A new therapeutic target has been discovered for metastatic bladder cancer, according to research presented June 26 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Chicago.

June 26, 2023

SNMMI: PET tracer describes clear cell renal cancer

By Amerigo Allegretto

A new PET tracer can accurately detect and differentiate a certain type of kidney cancer from other kidney tumor types, according to research presented June 26 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2023

SNMMI Image of the Year shows potential for pancreatic cancer theranostics

By Will Morton

CHICAGO - A new theranostic pair for imaging and treatment of pancreatic cancer has won the Image of the Year award at the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2023

Medical IP secures FDA clearance for CT body composition analysis AI

By AuntMinnie.com staff writers

South Korean AI firm Medical IP has secured clearance from the U.S. Food and Drug Administration (FDA) for its CT-based automatic body composition analysis AI software, DeepCatch.

June 25, 2023

Lunit secures Japanese reimbursement for CXR-AID

By AuntMinnie.com staff writers

Japan's Ministry of Health, Labor, and Welfare has approved Fujifilm Healthcare's AI algorithm for chest x-ray analysis CXR-AID for reimbursement. The algorithm is based on AI software developer Lunit's Insight CXR.

June 25, 2023

SNMMI names officers for 2023-2024 term

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released its slate of officers for the 2023-2024 term, with Helen Nadel, MD, as president.

June 25, 2023

Previous Page

Page 77 of 1553

Next Page